FemTech Summit – May 26-27 – free tickets

Basil Strategies and our event brand Doctors 2.0 & You  are excited to support the FemTech Summit, held online this year May 26-27, 2021, from 16:0020:00 CET

We look forward to the increasing use of digital technology (mobile apps, wearables,  home tests…) to support health issues related to contraception and fertility, gynecological symptoms, improving data collection from female patients. Denise Silber

What to expect?

  • You will discover the link between gender and effective therapy in medicine
  • You will be inspired by talks around Innovative Screening and Symptom Monitoring
  • You will gain valuable insights about the Future of pain + symptom management in gynecology
  • You will participate in relevant discussions on the personalization of contraception and fertility

Scroll to the end of the post for statistics on the state of women’s health.

Join the summit and register here: https://femtechnology.org.

Which start-ups will be present?

 > Ava: FDAcleared wearable tracking device to identify both the opening and closing of the fertile window.

> BloomLife: remote, personalised maternal and fetal healthcare.

> Clue: tracking the menstrual cycle to better understand how the female body works now an FDA approved form of contraception.

> Eli Health: an algorithm evaluating hormones in saliva to monitor the most fertile days.

> EndoDiag: developingnewdiagnostic solutionsfor endometriosis for healthcare professionals.

> Gynica: creating cannabisbased pharmacology for the female body.

> Haplomind: supportingperinatal depression and anxiety.

> Kheiron medical: using artificial intelligence to diagnose breast cancer

> Mobile ODT: using artificial intelligence for cervical screening, evaluation, and sexual assault forensics.

> Oui: makingcervicalmucus temporarily impenetrable to sperm.

> Syrona Health: personalising endometriosis care with insights and tracking.

> TestmateHealth: at home STDkits.

Some statistics:

  • Women are 50% more like to be given an incorrect diagnosis following a heart attack than men.
  • Drugs commonly prescribed to treat high blood pressure have been found to lower men’s mortality from heart attack – but increase cardiac related deaths among women.
  • In a 2008 study of textbooks used in Dutch medical schools, results from clinical trials were presented as valid for men + women, even when women were excluded from the studies. Sex specific information was absent even in topics where sex differences have long been established such as depression, effects of alcohol on the body… –
  • In 1977, an FDA policy banned most women of childbearing age from Phase I + early Phase II drug trials. It wasn’t until 1994 that the U.S. National Institutes of Health mandated that women be included in clinical trials.
    • Women in clinical studies are tested in the early phase of their cycle when hormone levels are lowest (i.e. most like men) to minimize the impacts oestradiol and progesterone may have on study outcomes.
    • Studies show menstrual cycle fluctuations impact antipsychotics, antihistamines, antibiotic treatments and heart medication.
  • Endometriosis is an incredibly painful condition in which tissue that lines the inside of the uterus is present on the outside of the uterus – it affects 1 in 10 women -and yet Women wait up to 7.5 YEARS on average from presenting symptoms to being diagnosed. –
  • Women in the US are now 2x as likely to die during pregnancy as their own mothers; yet more than 60% of pregnancy-related deaths are preventable.
  • Only 12% of the 50 million women diagnosed with Post Partum Depression receive treatment.
  • In India, where 22% of women are estimated to suffer from perinatal mood disorders, there are no dedicated maternal mental health regulations available.
  • In Switzerland the distinction between so-called “baby blues”, a normal emotional state, and the serious condition of Post Partum Depression is unclear.